SQZ Biotechnologies Co - ESG Rating & Company Profile powered by AI
This webpage displays a zero-cost Sustainability assessment covering SQZ Biotechnologies Co. If you are employed by SQZ Biotechnologies Co and you wish to use your Sustainability aseessment, please contact us. Browse to the bottom of the webpage for potential risks for SQZ Biotechnologies Co based on industry, geography and size.
SQZ Biotechnologies Co in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 4.0, social score of 4.8 and governance score of 4.8.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | SQZ Biotechnologies Co | 4.5 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does SQZ Biotechnologies Co have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose current and historical energy intensity?
Sign up for free to unlockDoes SQZ Biotechnologies Co report the average age of the workforce?
Sign up for free to unlockDoes SQZ Biotechnologies Co reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose its ethnicity pay gap?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose cybersecurity risks?
Sign up for free to unlockDoes SQZ Biotechnologies Co offer flexible work?
Sign up for free to unlockDoes SQZ Biotechnologies Co have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose the number of employees in R&D functions?
Sign up for free to unlockDoes SQZ Biotechnologies Co conduct supply chain audits?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes SQZ Biotechnologies Co conduct 360 degree staff reviews?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose the individual responsible for D&I?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose water use targets?
Sign up for free to unlockDoes SQZ Biotechnologies Co have careers partnerships with academic institutions?
Sign up for free to unlockDid SQZ Biotechnologies Co have a product recall in the last two years?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose incidents of discrimination?
Sign up for free to unlockDoes SQZ Biotechnologies Co allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas SQZ Biotechnologies Co issued a profit warning in the past 24 months?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose parental leave metrics?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose the pay ratio of women to men?
Sign up for free to unlockDoes SQZ Biotechnologies Co support suppliers with sustainability related research and development?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes SQZ Biotechnologies Co reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs SQZ Biotechnologies Co involved in embryonic stem cell research?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose its waste policy?
Sign up for free to unlockDoes SQZ Biotechnologies Co report according to TCFD requirements?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose energy use targets?
Sign up for free to unlockDoes SQZ Biotechnologies Co disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes SQZ Biotechnologies Co have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for SQZ Biotechnologies Co
These potential risks are based on the size, segment and geographies of the company.
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.